<p>(A) mRNA expression of CLDND1 in various breast cancer cell lines. MDA-MB-231, MDA-MB-468, BT-549 and MCF-7 cells were incubated under normal conditions for 24 h. Cells were subsequently harvested and were analyzed for mRNA expression of CLDND1 with real-time quantitative PCR. In B-E, MDA-MB-231, MDA-MB-468, BT-549 and MCF-7 cells respectively, were transfected with three different siRNA oligonucleotides targeting CLDND1 or with a control siRNA for 72 h. Cells were thereafter subjected to WST-1 assay. Data (mean ± S.E.M., n = 3) represent the amount of viable cells expressed as percent viable cells obtained under control conditions (B-E). Asterisks indicate statistically significant differences (*, p<0.05; **, p<0.01) compared with contr...
BackgroundEffector CD8+ T cell activation and its cytotoxic function to eradicate tumor cells depend...
<div><p>Cancer develops following the accumulation of genetic and epigenetic alterations that inacti...
INTRODUCTION: Triple-negative breast cancer (TNBC) is a heterogeneous disease with no definitive pro...
<p>MDA-MB-231, MDA-MB-468, BT-549, MCF-7 cells were transfected with three different siRNA oligonucl...
<p>MDA-MB-231 (A), MDA-MB-468 (B) and BT-549 (C) breast cancer cells were transfected with siRNA oli...
Identification of targets for apoptosis induction is important to provide novel therapeutic approach...
Identification of targets for apoptosis induction is important to provide novel therapeutic approach...
<p>(A) Expression of CHD1L protein in MDA-MB-231 cells (MDA231), MDA-MB-231 cells transfected with c...
Claudin 6 (CLDN6) was found to be a breast cancer suppressor gene, which is lowly expressed in breas...
BACKGROUND:The claudin 1 tight junction protein, solely responsible for the barrier function of epit...
<p>(<b>A</b>) PC3 cells were transfected with control siRNA (Ctrl) or ClpX- or ClpP-directed siRNA a...
CCND1 encodes for the cyclin D1 protein involved in G1/S cell cycle transition. In breast cancer the...
<p>A: cluster analysis and heat map of claudin 1 methylation (top), histogram of claudin 1 mRNA expr...
<p>(A) The CLPTM1L mRNA level after RNAi treatment was measured using quantitative real-time PCR in ...
Triple-negative breast cancer (TNBC) is a heterogeneous disease with no definitive prognostic marker...
BackgroundEffector CD8+ T cell activation and its cytotoxic function to eradicate tumor cells depend...
<div><p>Cancer develops following the accumulation of genetic and epigenetic alterations that inacti...
INTRODUCTION: Triple-negative breast cancer (TNBC) is a heterogeneous disease with no definitive pro...
<p>MDA-MB-231, MDA-MB-468, BT-549, MCF-7 cells were transfected with three different siRNA oligonucl...
<p>MDA-MB-231 (A), MDA-MB-468 (B) and BT-549 (C) breast cancer cells were transfected with siRNA oli...
Identification of targets for apoptosis induction is important to provide novel therapeutic approach...
Identification of targets for apoptosis induction is important to provide novel therapeutic approach...
<p>(A) Expression of CHD1L protein in MDA-MB-231 cells (MDA231), MDA-MB-231 cells transfected with c...
Claudin 6 (CLDN6) was found to be a breast cancer suppressor gene, which is lowly expressed in breas...
BACKGROUND:The claudin 1 tight junction protein, solely responsible for the barrier function of epit...
<p>(<b>A</b>) PC3 cells were transfected with control siRNA (Ctrl) or ClpX- or ClpP-directed siRNA a...
CCND1 encodes for the cyclin D1 protein involved in G1/S cell cycle transition. In breast cancer the...
<p>A: cluster analysis and heat map of claudin 1 methylation (top), histogram of claudin 1 mRNA expr...
<p>(A) The CLPTM1L mRNA level after RNAi treatment was measured using quantitative real-time PCR in ...
Triple-negative breast cancer (TNBC) is a heterogeneous disease with no definitive prognostic marker...
BackgroundEffector CD8+ T cell activation and its cytotoxic function to eradicate tumor cells depend...
<div><p>Cancer develops following the accumulation of genetic and epigenetic alterations that inacti...
INTRODUCTION: Triple-negative breast cancer (TNBC) is a heterogeneous disease with no definitive pro...